SAN DIEGO, June 6, 2023 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Dr. Helen Torley, president and chief executive officer, will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13, 2023, at 8 a.m. PT / 11 a.m. ET. A live…Read More
Halozyme to Present at the Goldman Sachs 44th Annual Global Healthcare Conference MarketScreener
